HEFEI COSOURCE PHARMACEUTICALS INC has a total of 12 patent applications. It increased the IP activity by 40.0%. Its first patent ever was published in 2017. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Taiwan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are KUNMING PHARMACEUTICAL GROUP, BOYEN THERAPEUTICS INC and ACADEMIC PHARM INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Taiwan | 2 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Steroids | |
#6 | Climate change adaptation technologies | |
#7 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Shanchun | 10 |
#2 | Peng Jiashi | 8 |
#3 | Cheng Kaisheng | 7 |
#4 | Wang Xiao | 7 |
#5 | Gao Shu | 6 |
#6 | Lu Xiaorong | 6 |
#7 | Yang Bin | 6 |
#8 | Sun Hongzhang | 6 |
#9 | Wang Yihua | 5 |
#10 | Xu Min | 3 |
Publication | Filing date | Title |
---|---|---|
TW202003045A | Lactulose glycoside compound, preparation method thereof and medicinal use thereof for providing the function of colon-localized drug release to prevent or treat the intestinal diseases | |
CN110650966A | Lactulose glycoside compound, preparation method and application thereof | |
US2021087144A1 | Insoluble complex or solvate thereof, pharmaceutical compostion and use thereof | |
CN109311883A | FLT3 kinase inhibitor or the crystal form of its salt and preparation method thereof | |
CN110177555A | Cycloartane tetracyclic triterpenoid, Its Preparation Method And Use |